June 30, 2011
AURORA, Ontario, June 30, 2011 – Helix BioPharma Corp. (TSX, NYSE Amex, FSE: “HBP”), a developer of
biopharmaceutical drug candidates for the prevention and treatment of cancer, today announced that Heman Chao, Ph.D.,
Chief Scientific Officer, will be presenting at the Fourteenth World Conference on Lung Cancer on July 5, 2011 at the
Amsterdam RAI Exhibition and Convention Centre, Netherlands.